Conclusion: However, high-quality studies remain needed. Copyright © 2017 John Wiley & Sons, Ltd.
PubMed 28165166 ↗Cissus
The short answer. There isn't much data on Cissus yet — 24 mentions, 7 with a clear outcome — so treat these numbers as anecdotal. It is most often used for pain & inflammation: 100% of 8 reports say that improved. It is well studied — 6 meta-analyses on PubMed.
From 24 mentions in total — the rest didn't say how it went and aren't counted.
What Cissus does, according to users
Of the people who reported each effect, the share who said it got better.
2 more with fewer than 3 reports
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 6 meta-analyses on PubMed ↗ · 13 randomized trials ↗
Conclusion: The CQ intervention was significantly associated with increased serum parathyroid hormone levels, with no significant effects on other bone-related biomarkers. Although there were a limited number of studies, these findings suggest its potential for modulating bone health; however, further research is needed to confirm these results and explore its clinical applications.
PubMed 40707943 ↗Conclusion: In conclusion, compounds containing ephedra, CQ, ginseng, bitter melon, and zingiber were found to be effective in the management of obesity. Attention to these natural compounds would open a new approach for novel therapeutic and more effective agents.
PubMed 19575486 ↗Conclusion: There is currently insufficient evidence to recommend any of the herbal medicines for weight loss included in the present review.
PubMed 31984610 ↗6 human trials on ClinicalTrials.gov test Cissus — 4 completed, 1 recruiting now. See all on ClinicalTrials.gov ↗
- A Study to Assess Effect of Glucocil® on Metabolic Health in Individuals With Prediabetes and Type 2 Diabetes Mellitus. · Pre Diabetes, Type2 Diabetes Mellitus · 2025
- Osteogenic Potential of Cissus Quadrangularis Alveolar Ridge Distraction · Distraction of Bone, Dental Implant · 2019
- Evaluation of Cissus Verticillata L. Infusion in Controlling Type 2 Diabetes · Diabetes · 2009
What government agencies say
Official records from US, Canadian and EU regulators, each linked to its source.
1 recall of products named for Cissus. Most recent:
- 2025-09-24 · Class III: Unapproved Drug Claims. record ↗
Class I = could cause serious harm; Class II = temporary or reversible harm; Class III = unlikely to cause harm. Recalls are of specific products and lots, not of the ingredient itself. All recalls (openFDA) ↗
Dosage people report
As stated by users — not a recommendation. Follow the label or your doctor.
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“This works more for bone regeneration but also reduces joint inflammation and seems to be helping me.”
“ive been taking cissus and can really feel a difference.”
“I took USPLabs Cissus and within about 3-4 weeks I had no more pain in my elbow.”
“I'd strongly recommend MSM or Cissus. It is for protecting your joints!”
Other options for pain & inflammation
Sources
- User reports: 24 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
- FDA recalls ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate